Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Descartes-15 by Cartesian Therapeutics for Refractory Multiple Myeloma: Likelihood of Approval
Descartes-15 is under clinical development by Cartesian Therapeutics and currently in Phase I for Refractory Multiple Myeloma. According to GlobalData,...
Descartes-15 by Cartesian Therapeutics for Relapsed Multiple Myeloma: Likelihood of Approval
Descartes-15 is under clinical development by Cartesian Therapeutics and currently in Phase I for Relapsed Multiple Myeloma. According to GlobalData,...
Descartes-15 by Cartesian Therapeutics for Autoimmune Disorders: Likelihood of Approval
Descartes-15 is under clinical development by Cartesian Therapeutics and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...